Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Kelonia Therapeutics, Inc.
Orca Biosystems, Inc.
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
M.D. Anderson Cancer Center
Turning Point Therapeutics, Inc.
Boston Scientific Corporation
Boston Scientific Corporation